Our Bodies Our Selves: The Future of Medicine 2020–2050

Take part in a fascinating rapid-fire journey through the looming revolutions in healthcare. The medical future is now, as information technology and improved imaging systems push the frontiers of prevention and cure on all fronts:

Portable sensors at home and multi-functional radiology in hospitals for detecting symptoms; ‘augmented reality’ apps enabling surgeons to see through anatomical structures prior to intervention; optogenetic uses of light to control cells in living tissue; 3D-printing of living cells and organs; genomic medicine to provide personalised DNA analysis at the patient’s bedside…

Read more

Diagnosis is being transformed by artificial intelligence. IBM Watson can read 200 million pages of text in 3 seconds and suggest appropriate therapies, while other programs can mine the data of medical records on a comparable scale. Computer-simulated clinical trials will bypass long and expensive procedures by using microchips to model human cells or organs; and remote audience participation in operating theatres will revolutionize the way medicine is taught.

On the patient’s side, the crowdsourcing of medical information and communication through social media augurs an era of universal access, just as 3D-printed drugs will transform the pharmaceutical industry and its monopolies of regulation and control. All of which suggests new ways for delivering health care in countries struggling to contain escalating costs.

The new mantra of public health will be to ensure populations live long but die fast, and the further frontiers combine science and fiction: uploading our minds onto a computer so as to exist posthumously in digital form, enhancing our lives by implanting recreational cyborgs: the eyesight of an eagle, the hearing of a bat… what kind of body would you like?

A group of expert communicators who are also authorities in their field will offer their fifteen-minute vision of the medical utopias – and dystopias? – which are now in our sights if not in our grasp.

Take part in a fascinating rapid- fire journey through the looming revolutions in healthcare.


Professor Karol Sikora


Professor Karol Sikora

Dean, University of Buckingham Medical School

Karol’s forty years’ experience as an oncologist has taught him that the effectiveness of treatment is more important than the organisation behind its delivery. While he still remains a Consultant Oncologist at Hammersmith Hospital, where he was Clinical Director for over 15 years, he launched Cancer Partners UK, Britain’s largest independent network of innovative cancer treatment centres in 2009. As a Fellow of Corpus Christi College, Cambridge, and a Dean and Professor of Medicine at Buckingham University, he writes and lectures regularly on the use of biomarkers and surrogate endpoints by using molecular diagnostics to personalise therapy.

Professor Paul Workman

Drugs of the Future

Professor Paul Workman

Chief Executive and President, The Institute of Cancer Research London

Professor Paul Workman is Chief Executive and President of The Institute of Cancer Research in London. He is a passionate advocate of personalised molecular medicine, and is an enthusiastic practitioner of multidisciplinary cancer drug discovery and development approaches to ‘drugging the cancer genome’. Paul has been responsible for more than 20 molecularly targeted cancer drugs entering clinical trial, including protein kinase, PI3 kinase and HSP90 inhibitors. He founded Chroma Therapeutics and Piramed Pharma and has won numerous awards, including being elected as a Fellow of the Royal Society in 2016.

Professor Martin Cowie


Professor Martin Cowie

Professor of Cardiology, the National Heart & Lung Institute

Martin Cowie is Professor of Cardiology at the National Heart & Lung Institute, in Imperial College. He is an Honorary Consultant Cardiologist at the Royal Brompton Hospital and a founding member and past-chairman of the British Society for Heart Failure. His major clinical and research interests are in health technology assessment and the delivery of efficient and effective care for patients with heart failure, with a particular focus on new technologies: diagnostics, drugs or devices. He has contributed chapters to many books, and has written a book for patients entitled ‘Living with Heart Failure – A Guide for Patients’. Professor Cowie is a Fellow of the Royal College of Physicians of London and a Fellow of the European Society of Cardiology.

Dr David Nyberg


Dr David Nyberg

Ultrasound diagnostic lead, The Medical Chambers Kensington

Dr David Nyberg is an internationally renowned expert in ultrasound.

David specialises in obstetric and gynaecologic ultrasound and is well known for his expertise in using prenatal scans to detect or exclude birth defects. He uses the latest equipment available, including 3D and 4D ultrasound, in order achieve the best possible ultrasound scans.

Dr Nyberg has authored and co-authored more than 150 medical papers on ultrasound and prenatal diagnosis and has written several authoritative textbooks. His papers have been published on early pregnancy and early pregnancy complications, including ectopic pregnancy, and he has given lectures across the world.


David’s research includes being a primary investigator for the FASTER (First and Second Trimester Evaluation of Risk) trial. This is the primary research that established the value of nuchal translucency (NT) and related testing methods for all patients in the United States. He was a primary author on the lead paper that examined these results, which was published in the New England Journal of Medicine.

David founded the Fetal and Women’s Center in Arizona where he established a network of clinics to offer fetal screening, testing and genetic counselling. He was amongst the first physicians in America to offer Non-Invasive Prenatal Testing (NIPT), and has now brought this expertise to London. He also founded www.MyUltrasoundPacs.com and the Ultrasound Network; and has developed several educational websites for patients and physicians including Fetal Screening.

Luke Johnson

Emerging Consumerism

Luke Johnson

Chairman, The Institute of Cancer Research

Luke Johnson has been the Chairman of The Institute of Cancer Research (ICR) since 2013. The ICR is one of the world’s leading medical laboratories focusing on defeating cancer. He is also the chairman of private equity house Risk Capital Partners LLP and holds numerous board positions across a diverse range of sectors. Luke is the Founder & Chairman of the Centre for Entrepreneurs and StartUp Britain and part-owner of Patisserie Holdings PLC, Bread Ltd (the firm behind the Gail’s artisan bakery chain). He co-founded Britain’s largest dental surgery chain, Integrated Dental Holdings, and studied Physiology at Oxford. Luke also writes a weekly column in The Sunday Times on entrepreneurship.

Professor Noel Fitzpatrick

Veterinary Medicine

Professor Noel Fitzpatrick

Managing Director, Fitzpatrick Referrals

Professor Noel Fitzpatrick is a world-class orthopaedic-neuro veterinary surgeon and the subject of the Channel 4 series, The Supervet. He is Managing Director of Fitzpatrick Referrals, a specialist veterinary referral hospital employing more than 200 staff which he established over ten years ago, and operates from two centres in Surrey. He is also a founding partner of Surrey University’s school of veterinary medicine. A trusted source of knowledge and information, he moves and inspires others with his leadership, his life enhancing treatments for animals and his teachings and his passion for One Medicine, which raises awareness of why it is vital to advance human and animal medicine at the same time.

Dr Raj Persaud


Dr Raj Persaud

Consultant Psychiatrist & Fellow, University College London and the Royal College of Psychiatrists

Dr Raj Persaud is a Consultant Psychiatrist who has worked at the Bethlem Royal and Maudsley NHS Hospitals in London. His experience is that Executive Coaching which takes people towards their goals and helps workplaces achieve targets, is not psychologically informed enough. He has written several books, 5 of which have been top ten best-sellers. The Times Newspaper also placed him as one of the top twenty Mental Health Gurus in the world. Recently he was elected Fellow of University College London and the Royal College of Psychiatrists.  He is patron or supporter of numerous mental health charities including OCD-UK, The Manic Depression Fellowship, ChildLine, Action Aid and The Samaritans.

Dr Mo Dewji

Primary Care

Dr Mo Dewji

National Clinical Lead (Primary Care), the Medical Directorate NHS

Dr Mo Dewji is a National Clinical Lead (Primary Care) within the Medical Directorate of the NHS, where he has been advising on the support of the Friends and Family Test in General Practice. His clinical interests lie in Paediatrics and GP Training. He acted as the clinical lead in the benchmarking of care across health systems and the active use of data to develop and deliver high quality care. He has been involved in the development of new commissioning models supporting CCG’s and practices, and has been an advisor to the development of the Diabetes NSF. Dr Dewji was previously the Chair of the Professional Executive of Milton Keynes Primary Care Trust and since the turn of the century has been a senior advisor to the Department of Health.

Lois Rogers

What People Really Want to Know

Lois Rogers

Medical Journalist

Lois Rogers is an award-winning international journalist, specialising in healthcare, life sciences and public policy. She was previously health and social affairs editor of The Sunday Times, and continues to contribute to the debate on the future of healthcare. Forming opinions by spotting social trends and emerging issues, Lois Rogers generates and writes news features across a variety of media outlets, and contributes to broadcast documentaries. She also provides specialist writing services to government departments, biotech companies and communications agencies; and advises on and writes patient/consumer information material. She has a particular interest in the emerging fields of nutraceuticals and cosmeceuticals. She has appeared as an expert witness for the House of Commons health select committee, and offers regular presentations at corporate and public sector events. She is a previous winner and runner up for Medical Journalist Association and Guild of Health Writers awards, and has received a variety of other journalistic commendations.

Dr Ameet Bakhai

Artificial Intelligence in Medicine

Dr Ameet Bakhai

Cardiology, the Royal Free London NHS Trust


Dr Ameet Bakhai, from the Royal Free London NHS Trust, is a unique, renowned, cardiologist and research lead, on the front line, who manages complex cardiac patients with an inspiring passion and proven track record for improving healthcare through constant innovations. He combines his care of patients with a depth of experience, clear communication and empathy whilst also providing access to cutting edge clinical trials, novel diagnostics, drugs, devices, digital technologies or recruiting them to international registries. As a “positive health hacker” he works with commissioners on value of medicines and technologies, pharma partners on designing and evaluating therapies and digital companies on integrating with treatment pathways.. As an ambassador for Digital Health London, his recent moonshot on Heart health and debate on Artificial Intelligence in medicine – enabling or replacing healthcare professionals highlights the need to understand the last 30 years of development from digital technology tools to Artificial Intelligence Health Care of the future.



2:00pm - 3:45pm



Introduction - Karol Sikora


Consumerism - Luke Johnson


The Mind - Raj Persaud


The Heart - Martin Cowie


Developing drugs - Paul Workman


Cancer - Karol Sikora

3:45pm - 4:15pm


4:15pm - 6:00pm



Primary Care - Mo Girach


Veterinary Medicine - Noel Fitzpatrick


Artificial Intelligence - Ameet Bakhai


Ultrasound - David Nyberg


The Media - Lois Rogers



Sponsored by


Royal Institution

21 Albemarle Street London W1S 4BS ‎ UK

Tube: Green Park, Bond Street, Oxford Circus, Piccadilly Circus
Bus: 9, 14, 19, 22 and 38